Current Concepts in the Etiology and Treatment of Keloids
Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas. Facial Plastic Surgery
(Impact Factor: 0.64).
10/2012; 28(5):504-12. DOI: 10.1055/s-0032-1325644
Keloids are benign, fibroproliferative growths that occur as a result of dermal injury in ~15% of the population. They are characterized by their extension beyond the confines of the original injury and often present with pain and pruritus. Additionally, these growths may result in cosmetic deformities and contribute to significant emotional distress. It is thought that keloids form as a result of aberrancies in the normal wound-healing process, which is complex and involves an elegant interplay between multiple cell types, cytokines, and proteins. The exact etiology is unknown, but significant research efforts have been made. These efforts have revealed that various cell types in keloids are either hyperresponsive and/or overproductive of various growth factors. Additionally, keloid cell types respond differently to mechanical strain than skin cells in patients who do not form keloids. This lack of understanding of keloid pathophysiology has left the care provider with a lack of a single definitive treatment strategy. Instead, a multitude of therapies exist ranging from surgery to injectables to lasers and any combination thereof. This purpose of this article is to highlight our current knowledge and emerging scientific understanding of keloid pathology and the current management strategies.
Available from: sung-no Jung
- "Keloids are defined as pathologic scars that grow beyond the confines of the original injury . They occur in areas of cutaneous injury, and they are benign, dermal fibroproliferative tumors, with no malignant potential  . They are characterized by an excessive deposition of extracellular matrix components, namely, collage, fibronectin, elastin, proteoglycans, and growth factors. "
[Show abstract] [Hide abstract]
ABSTRACT: Keloids and hypertrophic scars are thick, raised dermal scars, caused by derailing of the normal scarring process. Extensive research on such abnormal scarring has been done; however, these being refractory disorders specific to humans, it has been difficult to establish a universal animal model. A wide variety of animal models have been used. These include the athymic mouse, rats, rabbits, and pigs. Although these models have provided valuable insight into abnormal scarring, there is currently still no ideal model. This paper reviews the models that have been developed.
09/2013; 2013:423147. DOI:10.1155/2013/423147
Dermatologic Surgery 01/2014; 40(4). DOI:10.1111/dsu.12423 · 2.11 Impact Factor
Dermatologic Surgery 01/2014; 40(4). DOI:10.1111/dsu.12425 · 2.11 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.